Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,391,000 | 4,520,000 | 2,035,000 | 8,643,000 | 7,877,000 |
| Depreciation Amortization | 6,493,000 | 4,264,000 | 2,051,000 | 4,757,000 | 2,983,000 |
| Income taxes - deferred | 1,277,000 | 1,610,000 | 840,000 | -9,582,000 | 1,121,000 |
| Accounts receivable | N/A | N/A | N/A | 252,000 | N/A |
| Other Working Capital | -10,514,000 | -13,173,000 | -11,980,000 | 11,987,000 | -840,000 |
| Other Operating Activity | 2,549,000 | 1,292,000 | 694,000 | 530,000 | 621,000 |
| Operating Cash Flow | $5,196,000 | $-1,487,000 | $-6,360,000 | $16,587,000 | $11,762,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,475,000 | 7,517,000 | 9,210,000 | 12,808,000 | -25,401,000 |
| PPE Investments | -966,000 | -678,000 | -305,000 | -1,205,000 | -783,000 |
| Net Acquisitions | N/A | N/A | N/A | -43,123,000 | N/A |
| Purchase Of Investment | -2,674,000 | -1,481,000 | -858,000 | -6,888,000 | -6,053,000 |
| Sale Of Investment | 3,822,000 | 3,156,000 | 1,127,000 | 6,504,000 | 4,824,000 |
| Other Investing Activity | 496,000 | 519,000 | 220,000 | 632,000 | 508,000 |
| Investing Cash Flow | $5,153,000 | $9,033,000 | $9,394,000 | $-31,272,000 | $-26,905,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 4,686,000 | 3,169,000 | 1,892,000 | 32,033,000 | 28,473,000 |
| Debt Issued | N/A | N/A | N/A | 24,023,000 | 23,997,000 |
| Debt Repayment | -4,000 | -2,000 | -9,000 | -967,000 | -910,000 |
| Common Stock Repurchased | -1,000,000 | -500,000 | 0 | N/A | N/A |
| Dividend Paid | -4,544,000 | -2,995,000 | -1,441,000 | -5,548,000 | -4,268,000 |
| Other Financing Activity | -9,233,000 | -7,244,000 | -3,653,000 | -35,060,000 | -30,077,000 |
| Financing Cash Flow | $-10,095,000 | $-7,572,000 | $-3,211,000 | $14,481,000 | $17,215,000 |
| Exchange Rate Effect | -56,000 | -75,000 | -42,000 | 60,000 | 40,000 |
| Beginning Cash Position | 1,978,000 | 1,978,000 | 1,978,000 | 2,122,000 | 2,122,000 |
| End Cash Position | 2,176,000 | 1,877,000 | 1,759,000 | 1,978,000 | 4,234,000 |
| Net Cash Flow | $198,000 | $-101,000 | $-219,000 | $-144,000 | $2,112,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,196,000 | -1,487,000 | -6,360,000 | 16,587,000 | 11,762,000 |
| Capital Expenditure | -966,000 | -678,000 | -305,000 | -1,205,000 | -783,000 |
| Free Cash Flow | 4,230,000 | -2,165,000 | -6,665,000 | 15,382,000 | 10,979,000 |